| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,741 |
9,016 |
$617K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,379 |
7,618 |
$595K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,397 |
1,206 |
$67K |
| 99215 |
Prolong outpt/office vis |
837 |
785 |
$63K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
566 |
537 |
$40K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
513 |
506 |
$31K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
534 |
512 |
$28K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,319 |
3,248 |
$13K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
240 |
240 |
$13K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,229 |
1,204 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
690 |
675 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
164 |
158 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
90 |
87 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,696 |
2,410 |
$5K |
| 90686 |
|
1,219 |
1,192 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
88 |
88 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
27 |
27 |
$2K |
| 90682 |
|
44 |
43 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
161 |
158 |
$1K |
| 99000 |
|
1,861 |
1,683 |
$968.77 |
| 96127 |
|
746 |
723 |
$802.08 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
265 |
255 |
$643.11 |
| 90651 |
|
49 |
48 |
$598.60 |
| 36416 |
|
637 |
569 |
$513.42 |
| 90474 |
|
107 |
105 |
$494.57 |
| 90670 |
|
166 |
164 |
$438.12 |
| 81003 |
|
324 |
312 |
$361.42 |
| 90677 |
|
123 |
120 |
$298.26 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
37 |
28 |
$248.04 |
| 90698 |
|
358 |
352 |
$212.86 |
| 36415 |
Collection of venous blood by venipuncture |
190 |
177 |
$194.50 |
| 90633 |
|
53 |
52 |
$146.33 |
| 90680 |
|
120 |
116 |
$93.37 |
| 91301 |
|
17 |
15 |
$55.24 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
34 |
31 |
$44.82 |
| 90656 |
|
21 |
21 |
$44.78 |
| 90744 |
|
104 |
102 |
$37.95 |
| 90707 |
|
38 |
38 |
$0.08 |
| 90716 |
|
40 |
40 |
$0.08 |
| 90696 |
|
13 |
13 |
$0.05 |
| 90619 |
|
21 |
21 |
$0.01 |
| 3078F |
|
410 |
378 |
$0.00 |
| 99173 |
|
210 |
210 |
$0.00 |
| 90715 |
|
28 |
28 |
$0.00 |
| 3077F |
|
28 |
28 |
$0.00 |
| 3074F |
|
602 |
564 |
$0.00 |
| 3080F |
|
12 |
12 |
$0.00 |
| 3079F |
|
254 |
242 |
$0.00 |
| 3044F |
|
304 |
276 |
$0.00 |
| 3075F |
|
116 |
111 |
$0.00 |